Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway

被引:154
|
作者
Chen, Tongshuai [1 ,2 ,3 ]
Li, Jingyuan [1 ,2 ,3 ]
Liu, Junni [1 ,2 ,3 ]
Li, Na [1 ,2 ,3 ]
Wang, Shujian [1 ,2 ,3 ]
Liu, Hui [1 ,2 ,3 ]
Zeng, Mei [1 ,2 ,3 ]
Zhang, Yun [1 ,2 ,3 ]
Bu, Peili [1 ,2 ,3 ]
机构
[1] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Chinese Minist Publ Hlth, Jinan 250012, Shandong, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
resveratrol; fibrosis; cardiac function; sirtuin; 3; transforming growth factor-beta; mothers against decapentaplegic homolog 3; CALORIC RESTRICTION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; METABOLIC ADAPTATION; OXIDATIVE STRESS; PROTEIN-KINASE; MICE; BETA; HYPERTROPHY; HEART;
D O I
10.1152/ajpheart.00454.2014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sirtuins [sirtuin (SIRT) 1-SIRT7] mediate the longevity-promoting effects of calorie restriction in yeast, worms, flies, and mice. Additionally, SIRT3 is the only SIRT analog whose increased expression has been shown to be associated with longevity in humans. The polyphenol resveratrol (RSV) is the first compound discovered able to mimic calorie restriction by stimulating SIRTs. In the present study, we report that RSV activated SIRT3 in cardiac fibroblasts both in vivo and in vitro. Moreover, in wild-type mice, RSV prevented cardiac hypertrophy in response to hypertrophic stimuli. However, this protective effect was not observed in SIRT3 knockout mice. Additionally, the activation of SIRT3 by RSV ameliorated collagen deposition and improved cardiac function. In isolated cardiac fibroblasts, pretreatment with RSV suppressed fibroblast-to-myoblast transformation by inhibiting the transforming growth factor-beta/Smad3 pathway. Therefore, these data indicate that the activation of SIRT3 by RSV could ameliorate cardiac fibrosis and improve cardiac function via the transforming growth factor-beta/Smad3 pathway.
引用
收藏
页码:H424 / H434
页数:11
相关论文
共 50 条
  • [1] Resveratrol ameliorates pathological fibrosis of the myodural bridge by regulating the SIRT3/TGF-(31/Smad pathway
    Qin, Tao
    Song, Xue
    Shao, Qing
    Zhang, Jianfei
    Sui, Hongjin
    HELIYON, 2024, 10 (15)
  • [2] Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF-β/Smad3 Pathway
    Huang, Xin-Zhong
    Wen, Donghai
    Zhang, Min
    Xie, Qionghong
    Ma, Leting
    Guan, Yi
    Ren, Yueheng
    Chen, Jing
    Hao, Chuan-Ming
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (05) : 996 - 1005
  • [3] Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway
    Li, B.
    Chen, H.
    Yang, X.
    Wang, Y.
    Qin, L.
    Chu, Y.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (07) : 97 - 101
  • [4] Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway
    Zhang, Mingming
    Pan, Xietian
    Zou, Qian
    Xia, Yuesheng
    Chen, Jiangwei
    Hao, Qimeng
    Wang, Haichang
    Sun, Dongdong
    CARDIOVASCULAR TOXICOLOGY, 2016, 16 (04) : 316 - 324
  • [5] Notch3 Ameliorates cardiac Fibrosis after Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway
    Zhang Mingming
    Sun Dongdong
    Wang Haichang
    Wang, Haichang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C1 - C1
  • [6] Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway
    Mingming Zhang
    Xietian Pan
    Qian Zou
    Yuesheng Xia
    Jiangwei Chen
    Qimeng Hao
    Haichang Wang
    Dongdong Sun
    Cardiovascular Toxicology, 2016, 16 : 316 - 324
  • [7] NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway
    Zhou, Hongtao
    Yu, Xuefang
    Zhou, Guiming
    MOLECULAR MEDICINE REPORTS, 2017, 16 (03) : 3551 - 3556
  • [8] NLRC5 silencing improves cardiac fibrosis by regulation of TGF-β1/Smad3 signaling pathway
    Huang, Mingjian
    Pan, Chaoxin
    He, Xinbing
    Wang, Qinggao
    Wu, Wanli
    Yang, Qinghua
    Zhang, Zhenqian
    Wen, Zhihao
    Liang, Yiqiang
    Luo, Jinwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 12059 - +
  • [9] Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway
    Qu, Yubei
    Zhang, Liang
    Kang, Zechun
    Jiang, Wanglin
    Lv, Changjun
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 34 : 1 - 7
  • [10] Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway
    Zeng, Zifan
    Wang, Qiyan
    Yang, Xiaomin
    Ren, Yinglu
    Jiao, Shihong
    Zhu, Qingqing
    Guo, Dongqing
    Xia, Kai
    Wang, Yong
    Li, Chun
    Wang, Wei
    PHYTOMEDICINE, 2019, 62